Cargando…
Complete remission of lambda light chain myeloma presenting with acute renal failure following treatment with bortezomib and steroids
About one in five people with multiple myeloma produce only light chains. Patients with lambda light chain disease have a three times worse prognosis than kappa light chain disease. We report a case of lambda light chain deposition disease in a 35-year-old female who presented with acute renal failu...
Autores principales: | Pavan, M., Ashwini, K. A., Ravi, R., Suratkal, L. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931142/ https://www.ncbi.nlm.nih.gov/pubmed/20835325 http://dx.doi.org/10.4103/0971-4065.65304 |
Ejemplares similares
-
Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
por: Patibandla, Bhanu K., et al.
Publicado: (2014) -
Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma
por: Kishi, Seiji, et al.
Publicado: (2018) -
Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
por: Liu, Yang, et al.
Publicado: (2013) -
Treatment of Coexisting Chronic Neutrophilic Leukemia and Light Chain Multiple Myeloma with Hydroxyurea, Bortezomib, and Dexamethasone
por: Taiwo, Evelyn, et al.
Publicado: (2014) -
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2017)